drugset
drugset / Trial / NCT06010680

A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers

NCT06010680 ↗

Phase 1 Completed 6 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

Evaluate the Mass Balance of \[14C\]SHR2554 in Healthy Adult Male Volunteers.

Timeline

Start
2023-10-07
Primary completion
2023-11-27
Completion
2023-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR2554 Small molecule — —

Indications

lymphoma